since my message yesterday..who knows..sp improve a bit today .. some shareholdersmay have email tony...i have always said from day 1shareholders have rights...if they have a concern
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling